Takeda Pharmaceutical (TAK) Cash & Equivalents (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Cash & Equivalents of $2.89 billion for the quarter ended Jun 30, 2026, up 19.6% from $2.42 billion a year earlier but down 23.8% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Cash & Equivalents (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical's Cash & Equivalents came in at $3.95 billion, up 56.4% from the prior year.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -15.4% (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's Cash & Equivalents was $2.53 billion in the year ended Mar 31, 2025 (-31.7%), $3.7 billion in the year ended Mar 31, 2024 (-41.2%), $6.29 billion in the year ended Mar 31, 2023 (-26.9%) and $8.61 billion in the year ended Mar 31, 2022 (-5.6%).
- Quarterly Cash & Equivalents has run from a low of $1.95 billion in the quarter ended Dec 31, 2023 to a high of $7.31 billion in the quarter ended Mar 31, 2022 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 16.5% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Jun 30, 2024, with growth of 123.8%; the weakest was the quarter ended Dec 31, 2023, with a decline of 67.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $3.79 billion (quarter ended Mar 31, 2026), $4.26 billion (quarter ended Dec 31, 2025) and $4.63 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 2.89 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.89 Bn |
| Mar 31, 2026 | 3.79 Bn |
| Dec 31, 2025 | 4.26 Bn |
| Sep 30, 2025 | 4.63 Bn |
| Jun 30, 2025 | 2.42 Bn |
| Mar 31, 2025 | 2.52 Bn |
| Dec 31, 2024 | 3.25 Bn |
| Sep 30, 2024 | 5.76 Bn |
| Jun 30, 2024 | 5.17 Bn |
| Mar 31, 2024 | 3.09 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 3.69 Bn |
| Jun 30, 2023 | 2.31 Bn |
| Mar 31, 2023 | 4.03 Bn |
| Dec 31, 2022 | 6.01 Bn |
| Sep 30, 2022 | 6.15 Bn |
| Jun 30, 2022 | 6.57 Bn |
| Mar 31, 2022 | 7.31 Bn |
| Jun 30, 2021 | 5.98 Bn |
| Mar 31, 2021 | 9.13 Bn |
API Access
Takeda Pharmaceutical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();